This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Kyushu University, Mochida Pharmaceutical Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2017
Title: Yutaka Kiyohara: Innovator in Cardiovascular Disease Prevention
Introduction
Yutaka Kiyohara is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of cardiovascular health, particularly in the prevention of cardiovascular diseases. His innovative work has led to the development of a unique primary prevention agent aimed at individuals with elevated levels of high-sensitivity C-reactive protein.
Latest Patents
Yutaka Kiyohara holds a patent for a cardiovascular disease primary prevention agent specifically designed for patients with high blood levels of high-sensitivity C-reactive protein. This invention provides a method for lowering the risk of cardiovascular disease by administering a combination of EPA and its salts or esters to subjects with a blood hs-CRP level of 1.0 mg/L or higher, even if they have no prior history of cardiovascular disease. The patent also includes a combination marker for evaluating the primary risk of cardiovascular disease and methods for identifying high-risk subjects.
Career Highlights
Throughout his career, Kiyohara has worked with prominent organizations, including Mochida Pharmaceutical Co., Ltd. and Kyushu University. His research and innovations have been instrumental in advancing the understanding and prevention of cardiovascular diseases.
Collaborations
Some of his notable coworkers include Toshiharu Ninomiya and Takashi Yano. Their collaborative efforts have contributed to the success of Kiyohara's research and inventions.
Conclusion
Yutaka Kiyohara's work in developing a cardiovascular disease primary prevention agent highlights his commitment to improving public health. His innovative approach and collaboration with esteemed colleagues have positioned him as a key figure in the field of cardiovascular research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile